Status:
RECRUITING
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
Lead Sponsor:
UNICANCER
Collaborating Sponsors:
AstraZeneca
Merck Sharp & Dohme LLC
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospita...
Detailed Description
The database includes data related to patient demographics, tumor characteristics (diagnosis, histology, relapses, metastatic disease, etc.), treatments (dates, INN, route of administration, treatment...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Adult (over 18)
- Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site
- Exclusion criteria
- \- None
Exclusion
Key Trial Info
Start Date :
October 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
70000 Patients enrolled
Trial Details
Trial ID
NCT03848052
Start Date
October 2 2017
End Date
December 31 2025
Last Update
January 17 2025
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de l'Ouest - Paul Papin
Angers, France, 49933
2
Institut Bergonié
Bordeaux, France, 33076
3
Centre François Baclesse
Caen, France, 14076
4
Centre Jean Perrin
Clermont-Ferrand, France, 63011